Literature DB >> 1968473

Effects of buspirone in seven schizophrenic subjects.

D Brody1, L A Adler, T Kim, B Angrist, J Rotrosen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1968473     DOI： 10.1097/00004714-199002000-00025

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  4 in total

1.  Modification of cocaine self-administration by buspirone (buspar®): potential involvement of D3 and D4 dopamine receptors.

Authors:  Jack Bergman; Rebecca A Roof; Cheryse A Furman; Jennie L Conroy; Nancy K Mello; David R Sibley; Phil Skolnick
Journal:  Int J Neuropsychopharmacol       Date:  2012-07-25       Impact factor: 5.176

Review 2.  Differential changes in serotonin 5-HT1A and 5-HT2 receptor binding in patients with chronic schizophrenia.

Authors:  T Hashimoto; N Kitamura; Y Kajimoto; Y Shirai; O Shirakawa; T Mita; N Nishino; C Tanaka
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 3.  Use of psychotropic drugs in patients with HIV infection.

Authors:  J L Ayuso
Journal:  Drugs       Date:  1994-04       Impact factor: 9.546

4.  A triple-blinded, randomized, placebo-controlled trial to examine the efficacy of buspirone added to typical antipsychotic drugs in patients with chronic schizophrenia.

Authors:  Fatemeh Sheikhmoonesi; Mehran Zarghami; Seyyedeh Fatemeh Bahari Saravi; Alireza Khalilian; Shahram Ala
Journal:  J Res Med Sci       Date:  2015-02       Impact factor: 1.852
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.